Antioxidant micronutrients and cardiovascular risk in patients with diabetes: A systematic review;Micronutrientes antioxidantes e risco cardiovascular em pacientes com diabetes: Uma revisão sistemática

Arquivos Brasileiros de Cardiologia

Volumn 101, Issue 3, 2013, Pages 240-248

  Sarmento, Roberta Aguiar ^a,b   Silva, Flávia Moraes ^b   Sbruzzi, Graciele ^a   Schaan, Beatriz D'Agord ^a,b,c   de Almeida, Jussara Carnevale ^b,c  

^a INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Antioxidants; Cardiovascular diseases; Diabetes mellitus; Micronutrients; Risk factors

Indexed keywords

ALPHA TOCOPHEROL; ANTIDIABETIC AGENT; ANTIOXIDANT; ASCORBIC ACID; CHROMIUM; INSULIN; SELENIUM; TRACE ELEMENT; ZINC;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; META ANALYSIS (TOPIC); QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW;

ANTIOXIDANTS; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETIC DIET; HUMANS; MICRONUTRIENTS; RISK FACTORS;

EID: 84884783980     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.5935/abc.20130146     Document Type: Article

References (38)

1. Diaz MN, Frei B, Vita JA, Keaney JF Jr. Antioxidants and atherosclerotic heart disease. N Engl J Med. 1997;337(6):408-16.
2. Ye Z, Song H. Antioxidant vitamins intake and the risk of coronary heart disease: meta-analysis of cohort studies. Eur J CardiovascPrevRehabil. 2008;15(1):26-34.
3. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA.2007;297(8):842-57.
4. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics2009 update: a report fromthe American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation.2009;119(3):e21-181. Erratum in: Circulation. 2009;119(3):e182. Circulation. 2010;122(1):e11. Circulation. 2011;124(16):e424.
5. Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al;Emerging Risk Factors Collaboration. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829-41. Erratum in: N Engl J Med. 2011 Mar 31;364(13):1281
6. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615-25.
7. Penckofer S, Schwertz D, Florczak K. Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and pro-oxidants. J CardiovascNurs. 2002;16(2):68-85.
8. Martini LA, Catania AS, Ferreira SR. Role of vitamins and minerals in prevention and management of type 2 diabetes mellitus. Nutr Rev. 2010;68(6):341-54.
9. Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ, et al;American Diabetes Association. Nutrition recommendations and interventions for diabetes:a position statement of the American Diabetes Association. Diabetes Care. 2008;31Suppl 1:S61-78.
10. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340(2):115-26.
11. Higgins JPT, Green S. (editors). Cochrane handbook for systematic reviews of interventionsversion 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. [Cited in 2012 Dec 10]. Availablefrom: http://www. cochrane-handbook.org.
12. Rajpathak S, Rimm EB, Li T, Morris JS, Stampfer MJ, Willett WC, et al. Lower toenail chromium in men with diabetes and cardiovascular disease compared with healthy men. Diabetes Care. 2004;27(9):2211-6.
13. Lee DH, Folsom AR, Harnack L, Halliwell B, Jacobs Jr DR. Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes? Am J ClinNutr. 2004;80(5):1194-200.
14. Rajpathak S, Rimm E, Morris S, Hu F. Toenail selenium and cardiovascular disease in men with diabetes. J Am CollNutr. 2005;24(4):250-6.
15. Costacou T, Zgibor JC, Evans RW, Tyurina YY, Kagan VE, Orchard TJ. Antioxidants and coronary artery disease among individuals with type 1 diabetes: Findings from the Pittsburgh Epidemiology of Diabetes Complications Study. J Diabetes Complications. 2006;20(6):387-94.
16. Soinio M, Marniemi J, Laakso M, Pyorala K, Lehto S, Ronnemaa T. Serum zinc level and coronary heart disease events in patients with type 2 diabetes. Diabetes Care. 2007;30(3):523-8.
17. Asplund K. Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review. J Intern Med.2002;251(5):372-92.
18. Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. CurrMed Chem. 2005;12(10):1161-208.
19. Fernández-Real JM, López-Bermejo A, Ricart W. Cross-talkbetween iron metabolism and diabetes. Diabetes. 2002;51(8):2348-54.
20. Lee KW, Mossine V, Ortwerth BJ. The relative ability of glucose and ascorbate to glycate and crosslink lens proteins in vitro. off. Exp Eye Res. 1998;67(1):95-104.
21. Lee SH, Oe T, Blair IA. Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science. 2001;292(5524):2083-6.
22. US National Academy of Sciences. Dietary reference intakes for vitamin C, vitamin E, selenium and carotenoids. Washington DC: NationalAcademy Press; 2000.
23. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willet WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328(20):1444-9.
24. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willet WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328(20):1450-6.
25. Mayne ST. Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiologic research. J Nutr. 2003;133Suppl 3:933S-40S.
26. Steiner M. Influence of vitamin E on platelet function in humans. J Am CollNutr. 1991;10(5):466-73.
27. Reunanen A, Knekt P, Marniemi J, Mäki J, Maatela J, Aromaa A. Serum calcium, magnesium, copper and zinc and risk of cardiovascular death. Eur J ClinNutr. 1996;50(7):431-7.
28. Lee DH, Folsom AR, Jacobs Jr DR. Iron, zinc, and alcohol consumption and mortality from cardiovascular diseases: the Iowa Women's Health Study. Am J ClinNutr. 2005;81(4):787-91.
29. Anetor JI, Senjobi A, Ajose OA, Agbedana EO. Decreased serum magnesium and zinc levels: atherogenic implications in type-2 diabetes mellitusin Nigerians. NutrHealth. 2002;16(4):291-300.
30. Prasad AS. Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. ExpGerontol. 2008;43(5):370-7.
31. Chausmer AB. Zinc, insulin and diabetes. J Am CollNutr. 1998;17(2):109-15.
32. Guallar E, Jiménez FJ, van't Veer P, Bode P, Riemersma RA, Gómez-Aracena J, et al; EURAMIC-Heavy Metals and Myocardial Infraction Study Group. Low toenail chromium concentration and increased risk of nonfatal myocardial infarction. Am J Epidemiol. 2005;162(2):157-64.
33. Lai MH. Antioxidant effects and insulin resistance improvement of chromium combined with vitamin C and e supplementation for type 2 diabetes mellitus. J ClinBiochemNutr. 2008;43(3):191-8.
34. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577-89.
35. Balk EM, Tatsioni A, Lichtenstein AH, Lau J, Pittas AG. Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care. 2007;30(8):2154-63.
36. Flores-Mateo G, Navas-Acien A, Pastor-Barriuso R, Guallar E. Selenium and coronary heart disease: a meta-analysis. Am J ClinNutr. 2006;84(4):762-73.
37. Alissa EM, Bahijri SM, Ferns GA. The controversy surrounding selenium and cardiovascular disease: a review of the evidence. Med SciMonit. 2003;9(1):RA9-18.
38. Stranges S, Marshall JR, Trevisan M, Natarajan R, Donahue RP, Combs GF, et al. Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial. Am J Epidemiol. 2006;163(8):694-9.